262 related articles for article (PubMed ID: 37109674)
21. A comprehensive analysis of essential meiotic endonuclease 1 to prognosis and immune infiltration in kidney renal clear cell carcinoma.
Li HD; Ma HX; Ma JH; Kong SP; Zhao ST; Fan SQ; Qin F; Ma JG
Eur Rev Med Pharmacol Sci; 2024 Jan; 28(2):584-602. PubMed ID: 38305603
[TBL] [Abstract][Full Text] [Related]
22. Identification of small molecule drugs and development of a novel autophagy-related prognostic signature for kidney renal clear cell carcinoma.
Xing Q; Ji C; Zhu B; Cong R; Wang Y
Cancer Med; 2020 Oct; 9(19):7034-7051. PubMed ID: 32780567
[TBL] [Abstract][Full Text] [Related]
23. A novel ferroptosis-related 12-gene signature predicts clinical prognosis and reveals immune relevancy in clear cell renal cell carcinoma.
Hong Y; Lin M; Ou D; Huang Z; Shen P
BMC Cancer; 2021 Jul; 21(1):831. PubMed ID: 34281531
[TBL] [Abstract][Full Text] [Related]
24. Glutathione peroxidase family and survival prognosis in patients with renal cell carcinoma.
Li J; Huo S; Zhang R; Shi C; Sun N; Liu Q
Zhong Nan Da Xue Xue Bao Yi Xue Ban; 2022 May; 47(5):562-572. PubMed ID: 35753726
[TBL] [Abstract][Full Text] [Related]
25. System analysis of
Situ Y; Xu Q; Deng L; Zhu Y; Gao R; Lei L; Shao Z
Int J Biol Markers; 2022 Mar; 37(1):90-101. PubMed ID: 34870494
[TBL] [Abstract][Full Text] [Related]
26. A 9-gene prognostic signature for kidney renal clear cell carcinoma overall survival based on co-expression and regression analyses.
Zhu W; Ding M; Chang J; Liao H; Xiao G; Wang Q
Chem Biol Drug Des; 2023 Feb; 101(2):422-437. PubMed ID: 36053927
[TBL] [Abstract][Full Text] [Related]
27. OCLN as a novel biomarker for prognosis and immune infiltrates in kidney renal clear cell carcinoma: an integrative computational and experimental characterization.
Jia Z; Kong Y; Wang C; Fu Z; Tian Z; Sun Y; Lin Y; Huang Y
Front Immunol; 2023; 14():1224904. PubMed ID: 37809090
[TBL] [Abstract][Full Text] [Related]
28. Expression profile and prognostic values of GATA family members in kidney renal clear cell carcinoma.
Yang X; Mei C; Nie H; Zhou J; Ou C; He X
Aging (Albany NY); 2023 Mar; 15(6):2170-2188. PubMed ID: 36961416
[TBL] [Abstract][Full Text] [Related]
29. Potential Diagnostic and Prognostic Values of CBX8 Expression in Liver Hepatocellular Carcinoma, Kidney Renal Clear Cell Carcinoma, and Ovarian Cancer: A Study Based on TCGA Data Mining.
Lin J; Chen L; Wu D; Lin J; Liu B; Guo C
Comput Math Methods Med; 2022; 2022():1372879. PubMed ID: 35813444
[TBL] [Abstract][Full Text] [Related]
30. ZEB family is a prognostic biomarker and correlates with anoikis and immune infiltration in kidney renal clear cell carcinoma.
Lin S; Chen Q; Tan C; Su M; Min L; Ling L; Zhou J; Zhu T
BMC Med Genomics; 2024 Jun; 17(1):153. PubMed ID: 38840097
[TBL] [Abstract][Full Text] [Related]
31. CD72, a new immune checkpoint molecule, is a novel prognostic biomarker for kidney renal clear cell carcinoma.
Tian L; Wang Y; Zhang Z; Feng X; Xiao F; Zong M
Eur J Med Res; 2023 Nov; 28(1):531. PubMed ID: 37980541
[TBL] [Abstract][Full Text] [Related]
32. Comprehensive analysis on the expression levels and prognostic values of LOX family genes in kidney renal clear cell carcinoma.
Lin S; Zheng L; Lu Y; Xia Q; Zhou P; Liu Z
Cancer Med; 2020 Nov; 9(22):8624-8638. PubMed ID: 32970930
[TBL] [Abstract][Full Text] [Related]
33. A three-microRNA signature as a diagnostic and prognostic marker in clear cell renal cancer: An In Silico analysis.
Liang B; Zhao J; Wang X
PLoS One; 2017; 12(6):e0180660. PubMed ID: 28662155
[TBL] [Abstract][Full Text] [Related]
34. FMR1 is identified as an immune-related novel prognostic biomarker for renal clear cell carcinoma: A bioinformatics analysis of TAZ/YAP.
Wu S; He H; Huang J; Jiang S; Deng X; Huang J; Chen Y; Jiang Y
Math Biosci Eng; 2022 Jun; 19(9):9295-9320. PubMed ID: 35942760
[TBL] [Abstract][Full Text] [Related]
35. Comprehensive analysis of the HOXA gene family identifies HOXA13 as a novel oncogenic gene in kidney renal clear cell carcinoma.
Cui Y; Yan M; Zhang C; Xue J; Zhang Q; Ma S; Guan F; Cao W
J Cancer Res Clin Oncol; 2020 Aug; 146(8):1993-2006. PubMed ID: 32444962
[TBL] [Abstract][Full Text] [Related]
36. Expression and clinical significance of DOK3 in renal clear cell carcinoma.
Wang YF; Hu YQ; Hu YN; Bai YC; Wang H; Zhang Q
J Int Med Res; 2023 May; 51(5):3000605231174974. PubMed ID: 37235715
[TBL] [Abstract][Full Text] [Related]
37. A seven-gene signature model predicts overall survival in kidney renal clear cell carcinoma.
Chen L; Xiang Z; Chen X; Zhu X; Peng X
Hereditas; 2020 Sep; 157(1):38. PubMed ID: 32883362
[TBL] [Abstract][Full Text] [Related]
38. The promising novel biomarkers and candidate small molecule drugs in kidney renal clear cell carcinoma: Evidence from bioinformatics analysis of high-throughput data.
Zhang B; Wu Q; Wang Z; Xu R; Hu X; Sun Y; Wang Q; Ju F; Ren S; Zhang C; Qin L; Ma Q; Zhou YL
Mol Genet Genomic Med; 2019 May; 7(5):e607. PubMed ID: 30793530
[TBL] [Abstract][Full Text] [Related]
39. Prognostic Role of Long-Chain Acyl-Coenzyme A Synthetase Family Genes in Patients with Clear Cell Renal Cell Carcinoma: A Comprehensive Bioinformatics Analysis Confirmed with External Validation Cohorts.
Temiz MZ; Colakerol A; Sonmez SZ; Gokce A; Canitez IO; Ozsoy S; Kandirali E; Semercioz A; Muslumanoglu AY
Clin Genitourin Cancer; 2023 Feb; 21(1):91-104. PubMed ID: 36529627
[TBL] [Abstract][Full Text] [Related]
40. Establishment and validation of a novel peroxisome-related gene prognostic risk model in kidney clear cell carcinoma.
Zhang J; Zhao Q; Huang H; Lin X
BMC Urol; 2024 Jan; 24(1):26. PubMed ID: 38297313
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]